Showing posts with label carcinoma. Show all posts
Showing posts with label carcinoma. Show all posts

Thursday 13 December 2018

Human Papillomavirus Is Associated With The Development Of Skin Cancer

Human Papillomavirus Is Associated With The Development Of Skin Cancer.
The ubiquitous virus linked to cervical, vaginal and throat cancers may also introduce the danger of developing squamous cubicle carcinoma, the second most common form of skin cancer, a unique study suggests. The risk from human papillomavirus (HPV) seen in a new burn the midnight oil was even higher if people are taking drugs such as glucocorticoids to suppress the immune system, according to new research by an ecumenic team led by Dr Margaret Karagas of Dartmouth Medical School in Lebanon, NH.

But all of this does not surely mean that HPV causes squamous cell carcinoma, one expert said. "That's a sufficiently big leap to me," said Dr Stephen Mandy, a member of the American Society for Dermatologic Surgery and clinical professor of dermatology at the University of Miami Miller School of Medicine. "It's truly thinkable that people with high titers blood levels of HPV antibodies also have fleece cancer for other reasons".

There are vaccines already in use (such as Gardasil) that protect against the HPV strains that cause cervical cancer. But experts said that, given that there are more than 100 types of HPV, vaccines' watchful proficiency is unlikely to translate to another disease.

And "Does this mean if patients got the HPV vaccine they would be unsusceptible to squamous cell carcinoma? Probably not. I think it's a great curiosity but it's strict to define". Experts have already unearthed a link between HPV and skin cancer in patients who have had unit transplants (and are thus taking immunosuppressive drugs) and people with a rare genetic skin condition called epidermodysplasia verruciformis, who seem to be unusually accessible to infection with HPV.

The new study expands the search, looking to grasp if such a risk extends to the general population. The team compared HPV antibody levels in 663 adults with squamous chamber carcinoma, 898 people with basal apartment carcinoma (the most common type of skin cancer) and 805 healthy controls.